Last update:

Alzheimer's disease & dementia news

Medical research

Dietary compound increases longevity and protects against Alzheimer's disease in experimental models

Researchers from the Color and Food Quality group at the Faculty of Pharmacy (University of Seville), in collaboration with Dr. Marina Ezcurra's group at the University of Kent (U.K.), have shown that the carotenoid phytoene ...

Alzheimer's disease & dementia

Questions over safety and effectiveness of new Alzheimer's drug

The safety and effectiveness of donanemab—an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA)—is called into question in an investigation published by The BMJ.

Genetics

Master copper regulator discovery may offer Alzheimer's clues

New therapeutic opportunities often emerge from research on simple organisms. For instance, the 2020 Nobel Prize in Chemistry awarded to Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., for their CRISPR-based DNA ...

Alzheimer's disease & dementia

Boosting brain protein levels may slow decline from Alzheimer's

A study published in the journal Brain shows that increases in protein levels with new Alzheimer's drugs can explain the slowing of cognitive impairment at least as well as the reduction in amyloid plaques.

Medical research

Molecule reduces inflammation in Alzheimer's models

Though drug developers have achieved some progress in treating Alzheimer's disease with medicines that reduce amyloid-beta protein, other problems of the disease including inflammation, continue unchecked. In a new study, ...

Alzheimer's disease & dementia

Q&A: The signs of dementia and what can be done to stave it off

The number one risk factor for Alzheimer's disease is age, far more than genetics. Because of the aging of the U.S. population, there are currently 6.7 million Americans with dementia, including Alzheimer's.

Alzheimer's disease & dementia

New risk score strongly predicts dementia chances within 14 years

A new dementia risk score, which draws on 11 mostly modifiable risk factors, identifies people at risk—from midlife onward—of developing the disease within the next 14 years, suggests a large long term study published ...

Alzheimer's disease & dementia

Intermittent fasting improves Alzheimer's pathology in mouse model

One of the hallmarks of Alzheimer's disease is disruption to the body's circadian rhythm, the internal biological clock that regulates many of our physiological processes. Nearly 80% of people with Alzheimer's experience ...

Neuroscience

'Viral relicts' in the genome could fuel neurodegeneration

Genetic remnants of viruses that are naturally present in the human genome could affect the development of neurodegenerative diseases. Researchers at DZNE have come to this conclusion based on studies of cell cultures. In ...